Dexmedetomidine as an Adjunctive Sedative in Patients Undergoing Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis
2024

Dexmedetomidine for Sedation in Endoscopic Procedures

Sample size: 836 publication Evidence: moderate

Author Information

Author(s): Abosheaishaa Hazem MD, MSc, Abdallfatah Abdallfatah MS, Abdelghany Abdelmalek MS, Sethi Arshia MD, Ismail Abdellatif MD, Mohamed Doha MS, Aboeldahb Moataz MD, Abdelhalim Omar MD, Mohamed Islam MD, Azzam Ahmed Y. MD, MEng, Essibayi Muhammed Amir MD, Altschul David J., Nassar Mahmoud MD, Bilal Mohammad MD

Primary Institution: Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals, Queens, New York, USA.

Hypothesis

Is dexmedetomidine an effective adjunctive sedative for patients undergoing endoscopic submucosal dissection?

Conclusion

Dexmedetomidine is safe and effective for sedation during endoscopic submucosal dissection, reducing restlessness without significant adverse events.

Supporting Evidence

  • Dexmedetomidine significantly reduced restlessness compared to controls.
  • Dexmedetomidine increased the risk of bradycardia.
  • No significant difference in en-bloc or complete resection rates between dexmedetomidine and control groups.
  • Sedation and procedure times were similar between dexmedetomidine and control groups.

Takeaway

Dexmedetomidine helps keep patients calm and comfortable during certain medical procedures without causing serious side effects.

Methodology

A systematic review and meta-analysis of studies involving dexmedetomidine as an adjunctive sedative during endoscopic submucosal dissection.

Potential Biases

Some studies had a moderate risk of bias, and most did not conduct head-to-head comparisons.

Limitations

The studies included were primarily from Eastern Asia, limiting generalizability, and there was no standardized dosage of dexmedetomidine.

Participant Demographics

Patients undergoing endoscopic submucosal dissection for gastrointestinal adenomas and early-stage neoplastic lesions.

Statistical Information

P-Value

p=0.52 for en-bloc resection, p=0.38 for complete resection, p=0.14 for sedation time, p=0.51 for procedure time, p<0.00001 for restlessness, p<0.00001 for bradycardia.

Confidence Interval

95% CI: 0.07 to 0.29 for restlessness, 95% CI: 3.17 to 16.11 for bradycardia.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1101/2024.11.14.24317324

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication